October 12, 2015 by Geoff Walden and Chain Drug Review
chain drug industry, CVS Health, Empire Co., Express Scripts, Jean Coutu Group, Metro Inc., Rexall Health, Rite Aid, Shoppers Drug Mart, Stefano Pessina, Target Corp., Walgreens Boots Alliance, Walmart
2015, Business, Issue 10-12-2015, Issues, Leading Headlines, News, Retail News
NEW YORK — As much as the chain drug industry has consolidated, there is room for more mergers and acquisitions. That’s evident from the M&A speculation swirling about the sector in the U.S. and Canada, as well as recent activity. Lending credibility to the speculation is none other than Walgreens Boots Alliance (WBA) chief executive
October 12, 2015 by David Pinto and Chain Drug Review
Alex Gourlay, chain drug retailing, CVS Health, David Pinto, Helena Foulkes, John Standley, Ken Martindale, Larry Merlo, Ornella Barra, Rite Aid, Walgreens, Walgreens Boots Alliance
2015, Issue 10-12-2015, Issues, Opinion
As the year 2015 winds down, the chain drug community must face the reality that the coming year will be unlike any that has preceded it. The same drug chains still rule the U.S. landscape. But the content of their character and the face of the people who guide them are vastly different than in
September 28, 2015 by Geoff Walden and Chain Drug Review
CVS Health, CVS/pharmacy, Fortune magazine, Helena Foulkes, Most Powerful Women, Ornella Barra, Walgreens Boots Alliance
2015, Issue 09-28-2015, Issues, News
NEW YORK — Chain drug executives Helena Foulkes and Ornella Barra are among the “Most Powerful Women” in business listed by Fortune magazine. Foulkes, president of CVS/pharmacy, was ranked 14th on the list of 51 women in the U.S. Barra, president and chief executive officer of global wholesale and international retail at Walgreens Boots Alliance
September 22, 2015 by Chain Drug Review
AmerisourceBergen, Cardinal Health, Celesio, CVS Health, drug channel, drug wholesalers, Fitch Ratings, generic drugs, McKesson, UDG Healthcare, Walgreens Boots Alliance
CDR Blog
McKesson’s deal to buy Ireland’s UDG Healthcare reflects the global consolidation of health care distribution, as drug wholesalers continue their drive for scale, especially in the realm of generic drugs, according to Fitch Ratings. “The UDG deal will add to McKesson’s generic purchasing power and further enhance its European pharmaceutical distribution presence, following its acquisition
September 22, 2015 by Chain Drug Review
AmerisourceBergen, share repurchase program, Steven Collis, Walgreens Boots Alliance
Business, Supplier News
VALLEY FORGE, Pa. — The board of directors at AmerisourceBergen Corp. has authorized a special $2.4 billion share repurchase program. AmerisourceBergen said Tuesday the new stock buyback program will facilitate the execution of its previously announced warrant hedging strategy as well as mitigate the dilution of shareholders’ ownership interests that may result from the issuance
August 10, 2015 by Geoff Walden and Chain Drug Review
Alliance Boots, Jim Skinner, Stefano Pessina, Walgreens, Walgreens Boots Alliance
2015, Issue 08-10-2015, Issues, News
DEERFIELD, Ill. — As chief executive officer of Walgreens Boots Alliance Inc. (WBA), Stefano Pessina says he will provide management stability, enabling the company to focus on its operational and strategic tasks. He says the WBA board appointed him CEO (he had been in the role on an interim basis), rather than choose a new
August 3, 2015 by Chain Drug Review
chief accounting officer, global controller, Kimberly Scardino, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — Kimberly Scardino has joined Walgreens Boots Alliance Inc. as senior vice president, global controller and chief accounting officer. Walgreens Boots Alliance said late Monday that Scardino comes to the company from American Express Co., where she was senior vice president and business advisory controller. Before that role, she served as senior vice president
July 16, 2015 by Geoff Walden and Chain Drug Review
Jeffrey Berkowitz, Merck, Pharma and Global Market Access, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Jeff Berkowitz, executive vice president at Walgreens Boots Alliance and president of Pharma and Global Market Access, has left the company. “With the restructuring of our Pharma and Global Market Access group, Jeff Berkowitz, who has led that function since its formation, has made the decision to pursue other opportunities outside the
July 9, 2015 by Chain Drug Review
Deutsche Bank Securities, fiscal 2015 third quarter, George Hill, James Skinner, Liz Earle Beauty, Mark Miller, Stefano Pessina, Walgreens, Walgreens Boots Alliance, William Blair & Co.
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. announced executive vice chairman Stefano Pessina as its permanent chief executive officer in reporting increased sales and earnings for its fiscal 2015 third quarter. The company said Thursday that its board of directors appointed Pessina as CEO, effective immediately. He had been serving as acting CEO since January,
June 15, 2015 by Chain Drug Review and Chain Drug Review
Anthony Roberts, chief information officer, CIO, Tim Theriault, Walgreens Boots Alliance
2015, Issue 06-15-2015, News
DEERFIELD, Ill. — Anthony Roberts has taken the reins as senior vice president and global chief information officer at Walgreens Boots Alliance Inc. Roberts, previously senior vice president and international CIO, was promoted to the position when Tim Theriault, executive vice president and global CIO, stepped down effective June 1 for personal reasons. Plans call
June 15, 2015 by David Pinto and Chain Drug Review
CVS, David Pinto, retailing, retailing companies, Target, Walgreens Boots Alliance, Walmart’s annual meeting
2015, Issue 06-15-2015, Opinion
Retailing is making headlines in the consumer press these days — the wrong kind of headlines. Some samples include the following: • CVS is being accused of targeting African-American and Hispanic shoppers as more likely to cause trouble than are Caucasian customers. • Walmart has reluctantly agreed to lower the temperature — by one degree
June 1, 2015 by Mark Baumgartner and Chain Drug Review
Alex Gourlay, Linn Jordan, Red Nose Day, Red Nose Fund, Walgreens, Walgreens Boots Alliance
2015, Issue 06-01-2015, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) says it exceeded its initial goal of raising $5 million in support of the Red Nose Day campaign to raise money for children and young people living in poverty. As of Red Nose Day, WBA had raised $7 million, according to Linn Jordan, director of marketing, strategy
June 1, 2015 by Jeffrey Woldt and Chain Drug Review
Alex Gourlay, Jeffrey Woldt, Walgreens, Walgreens Boots Alliance
2015, Issue 06-01-2015, Opinion
Most people in this country spent last Christmas Eve away from work, celebrating the holiday with family members and friends. Alex Gourlay, then Walgreens’ president of customer experience and daily living, devoted much of the day to visiting a dozen of the drug chain’s outlets in greater Chicago. His goal was to connect with store-level
May 29, 2015 by Chain Drug Review and Chain Drug Review
Anthony Roberts, chief information officer, global CIO, Stefano Pessina, Tim Theriault, Walgreens, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Tim Theriault, executive vice president and global chief information officer at Walgreens Boots Alliance Inc., is stepping down as of June 1. Walgreens said Friday that Theriault is leaving the CIO position for personal reasons. He has served as the drug chain’s CIO for more than five years. Anthony Roberts, who has served